----
Current ValuationThe current P/E ratio is 19.16, within the reasonable range, cheaper than 45.86% of the time in the past 5 years, and the industry ranks 38/222, the industry Median 23.02.
19.16xP/E
¥9.01Stock price
¥0.47Earnings per share
19.16xP/E
Stock price¥9.01Earnings per share¥0.47
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 18.67x
- Typical range
- 15.39x–22.68x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 23.02x
016324864
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 23.02x
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
000538SZYunnan Baiyao | 18.79x | 6.70% | ¥97.71B |
600196SHFOSUN PHARMA | 17.98x | 7.35% | ¥63.18B |
000999SZCR Sanjiu | 13.38x | 3.26% | ¥43.15B |
688578SHAllist | 13.44x | 31.69% | ¥39.06B |
000423SZDEEJ | 18.01x | 9.19% | ¥32.33B |
600079SHHWHG | 12.32x | 28.07% | ¥31.80B |
000513SZLIVZON GROUP | 17.57x | 21.43% | ¥27.37B |
002603SZYILING PHARMACEUTICAL | 19.48x | 14.94% | ¥26.92B |
600566SHJUMPCAN | 14.68x | -- | ¥26.67B |
600535SHTASLY | 17.64x | 13.44% | ¥21.57B |
000623SZJI LIN AO DONG | 6.92x | -- | ¥20.71B |
600380SHJoincare | 16.97x | 15.07% | ¥19.19B |
600062SHCR Double-Crane | 10.73x | 2.02% | ¥16.72B |
600267SHHISUN | 13.32x | 58.70% | ¥16.32B |
600750SHCRJZ | 17.55x | 3.87% | ¥14.75B |
600285SHLingrui Pharma | 16.16x | 9.20% | ¥13.37B |
300573SZXingqi Pharmaceutical | 16.07x | -- | ¥12.89B |
605507SHGuobang Pharma | 19.89x | 12.03% | ¥12.37B |
002287SZCheezhengTTM | 17.73x | -- | ¥11.20B |
900917SHHX GROUP | 10.84x | -- | ¥311.42M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
